Everest Medicines drug wins Korea approval
South Korea’s Ministry of Food and Drug Safety has approved Everest Medicines’ new drug application for Velsipity. The treatment is indicated for adults with moderate to severe active ulcerative colitis who have had an inadequate response to, or intolerance of, conventional therapies or biologics.